Heartburn Drug Zantac Must be Fully Removed From Shelves Because Of Cancer Risk, Says FDA

Updated April 9th, 2020

Heartburn Drug Zantac Must be Fully Removed From Shelves Because Of Cancer Risk, Says FDA

An impurity in the ingredient ranitidine has been found to increase cancer-risk over time. Find out what over-the-counter heartburn remedies you can safely take instead:

NOW
PLAYING
What You Need to Know About Cisplatin Chemotherapy Treatment for Advanced-Stage Bladder Cancer
NOW
PLAYING
New Hope For Some Early-Stage Breast Cancer Patients: FDA Approves Targeted Therapy Drug Verzenio
NOW
PLAYING
5 Tips on How to Use Cannabis For Cancer
NOW
PLAYING
What Are the Side Effects of Immunotherapy for Bladder Cancer?
NOW
PLAYING
ENHERTU Is A 'Big Game Changer' for HER2 Positive Metastatic Breast Cancer Patients
NOW
PLAYING
Pfizer Issues Nationwide Recall of Anti-Smoking Drug Chantix

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.